Evidence map›Paper›PMID 35734537›Full record

ArticleInfection and drug resistance2022

Knowledge of Malaria and Its Uncomplicated Treatment with

Tamirat Tekassa, Gemmechu Hasen, Hailu Merga, Anne-Laure Cavin, Bertrand Graz, Sultan Suleman

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Infection and drug resistance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tamirat TekassaSchool of Pharmacy, Institute of Health, Jimma University, Jimma, Oromia Regional State, Ethiopia.
Gemmechu HasenSchool of Pharmacy, Institute of Health, Jimma University, Jimma, Oromia Regional State, Ethiopia.ORCID 0000-0002-1693-0240
Hailu MergaDepartment of Epidemiology, Institute of Health, Jimma University, Jimma, Oromia Regional State, Ethiopia.ORCID 0000-0001-7536-4755
Anne-Laure CavinMedicines Unit, Antenna Foundation, Geneva, Switzerland.
Bertrand GrazMedicines Unit, Antenna Foundation, Geneva, Switzerland.
Sultan SulemanSchool of Pharmacy, Institute of Health, Jimma University, Jimma, Oromia Regional State, Ethiopia.
Jimma University · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: With the problems of increasing levels of drug resistance and difficulties to afford and access effective antimalarial drugs in poor and remote areas, herbal medicines could be an important and sustainable source of treatment. Methods: A community-based cross-sectional study was conducted in two selected districts in Jimma Zone, southwest Ethiopia. In total, 552 participants from 17 kebeles (villages/communities) and 18 traditional healers of the districts were interviewed. Data collection was conducted from April 27 to May 18, 2020 using pre-tested structured questionnaires. The data were analyzed using Epi Info 7.0 and the descriptive statistics were used to summarize the results. Results: The study indicated that AM is available, known by 39.8% of the respondents and used for prevention and treatment of malaria by 5.7% of the population. All traditional healers interviewed knew the plant, and 44.4% use it for treatment of malaria. In addition, AM is especially used to treat malaria, amoebiasis, diarrhea, cough, and tuberculosis. Conclusion: The availability and use of AM to treat malaria was verified in both community and traditional healers. AM, which was found effective as antimalarial plant in high

Indexed as

antimalarialsArgemone mexicana L.Malariatraditional medicine

Identifiers

PMID35734537
PMCPMC9208626
OpenAlexW4282959438

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.